Central nervous system vasculitis: Still more questions than answers

Current Neuropharmacology

Volumn 9, Issue 3, 2011, Pages 437-448

  Alba, Marco A ^a   Espígol Frigolé, Georgina ^a   Prieto González, Sergio ^a   Tavera Bahillo, Itziar ^a   García Martínez, Ana ^a   Butjosa, Montserrat ^a   Hernández Rodríguez, José ^a   Cid, Maria C ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Central nervous system; Vasculitis

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; GLUCOCORTICOID; INFLIXIMAB; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; PREDNISONE;

ANGIOGRAPHY; AORTA ARCH SYNDROME; ARTICLE; BEHCET DISEASE; BRAIN BIOPSY; CENTRAL NERVOUS SYSTEM VASCULITIS; CEREBROSPINAL FLUID ANALYSIS; CHURG STRAUSS SYNDROME; CLINICAL FEATURE; CRYOGLOBULINEMIA; GIANT CELL ARTERITIS; HISTOPATHOLOGY; HUMAN; LARGE VESSEL VASCULITIS; MAGNETIC RESONANCE ANGIOGRAPHY; MICROSCOPIC POLYANGIITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PATHOLOGY; POLYARTERITIS NODOSA; PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM; REVASCULARIZATION; REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME; VASCULITIS; WEGENER GRANULOMATOSIS;

EID: 79961003358     PISSN: 1570159X     EISSN: 18756190     Source Type: Journal    
DOI: 10.2174/157015911796557920     Document Type: Article

References (116)

1. Calabrese, L.H.; Mallek, J.A. Primary angiitis of the central nervous system, report of 8 new cases: review of the literature and proposal for diagnostic criteria. Medicine, 1988, 67, 20-39.
2. Birnbaum, J.; Hellmann, D.B. Primary angiitis of the central nervous system. Arch. Neurol., 2009, 66, 704-709.
3. Lie, J.T. Classification and histopathologic spectrum of central nervous system vasculitis. Neurol. Clin., 1997, 15, 805-819.
4. Sigal, L.H. The neurologic presentation of vasculitic and rheumatologic syndromes. A review. Medicine, 1987, 66, 157-180.
5. Scolding, N.J. Central Nervous System Vasculitis. Semin. Immunopathol., 2009, 31, 527-536.
6. Benseler, S.M.; Silverman, E.; Aviv, R.I.; Schneider, R.; Armstrong, D.; Tyrrell, P.N.; deVeber, G. Primary vasculitis of the central nervous system in children. Arthritis. Rheum., 2006, 54, 1291-1297.
7. Elbers, J.; Benseler, S.M. Central nervous system vasculitis in children. Curr. Opin. Rheumatol., 2008, 20, 47-54.
8. Cantez, S.; Benseler, S.M. Childhood central nervous system vasculitis: a treatable cause of new neurological deficit in children. Nat. Clin. Pract. Rheumatol., 2008, 4, 460-461.
9. Salvarani, C.; Brown, R.D. Jr; Calamia, K.T.; Christianson, T.J.; Weigand, S.D.; Miller, D.V.; Giannini, C.; Meschia, J.F.; Huston, J. 3rd; Hunder, G.G. Primary central nervous system vasculitis, analysis of 101 patients. Ann. Neurol., 2007, 62, 442-451.
10. Amlie-Lefond, C.; Kleinschmidt-DeMasters, B.K.; Mahalingam, R.; Davis, L.E.; Gilden, D.H. The vasculopathy of varicella-zoster virus encephalitis. Ann. Neurol., 1995, 37, 784-790.
11. Yankner, B.A.; Skolnik, P.R.; Shoukimas, G.M.; Gabuzda, D.H.; Sobel, R.A.; Ho, D.D. Cerebral granulomatous angiitis associated with isolation of human T-lymphotropic virus type III from the central nervous system. Ann. Neurol., 1986, 20, 362-364.
12. Gray, F.; Hurtrel, M.; Hurtrel, B. Early central nervous system changes in human immunodeficiency virus (HIV)-infection. Neuropathol. Appl. Neurobiol., 1993, 19, 3-9.
13. Reuter, J.D. Cytomegalovirus induces T-cell independent apoptosis in brain during immunodeficiency. J. Clin. Virol., 2005, 32, 218- 223.
14. Linnemann, C.C. Jr; Alvira, M.M. Pathogenesis of varicella-zoster angiitis in the CNS. Arch. Neurol., 1980, 37, 239-240.
15. Calabrese, L.H. Infection with the human immunodeficiency virus type 1 and vascular inflammatory disease. Clin. Exp. Rheumatol., 2004, 22 (suppl), S87-93.
16. Lie, J.T. Primary (granulomatous) angiitis of the central nervous system: a clinicopathologic analysis of 15 new cases and a review of the literature. Hum. Pathol., 1992, 23, 164-171.
17. Sethna, M.P.; Lampson, L.A. Immune modulation within the brain, recruitment of inflammatory cells and increased major histocompatibility antigen expression following intracerebral injection of interferon-gamma. J. Neuroimmunol., 1991, 34, 121-32.
18. Akassoglou, K.; Douni, E.; Bauer, J.; Lassmann, H.; Kollias, G.; Probert, L. Exclusive tumor necrosis factor (TNF) signaling by the p75TNF receptor triggers inflammatory ischemia in the CNS of transgenic mice. Proc. Natl. Acad. Sci. USA, 2003, 100, 709-714.
19. Hirohata, S.; Tanimoto, K.; Ito, K. Elevation of cerebrospinal fluid interleukin-6 activity in patients with vasculitides and central nervous system involvement. Clin. Immunol. Immunopathol., 1993, 66, 225-229.
20. Miller, D.V.; Salvarani, C.; Hunder, G.G.; Brown, R.D.; Parisi, J.E.; Christianson, T.J.; Giannini, C. Biopsy findings in primary angiitis of the central nervous system. Am. J. Surg. Pathol., 2009, 33, 35-43.
21. Myung, J.; Kim, B.; Yoon, B.W.; Lee, S.K.; Sung, J.J.; Chung, C.K.; Chang, K.H.; Park, S.H. B-cell dominant lymphocytic primary angiitis of the central nervous system, Four biopsy-proven cases. Neuropathology, 2010, 30, 123-130.
22. Calabrese, L.H.; Duna, G.F.; Lie, J.T. Vasculitis in the central nervous system. Arthritis Rheum., 1997, 40, 1189-1201.
23. Scolding, N.J.; Jayne, D.R.; Zajicek, J.P.; Meyer, P.A.R.; Wraight, E.P.; Lockwood, C.M. The syndrome of cerebral vasculitis, recognition; diagnosis and management. Q. J. Med., 1997, 90, 61-73.
24. MacLaren, K.; Gillespie, J.; Shrestha, S.; Neary, D.; Ballardie, F.W. Primary angiitis of the central nervous system: emerging variants. Q. J. Med., 2005, 98, 643-654.
25. Molloy, E.S.; Singhal, A.B.; Calabrese, L.H. Tumour-like mass lesion, an under-recognised presentation of primary angiitis of the central nervous system. Ann. Rheum. Dis., 2008, 67, 1732-1735.
26. Salvarani, C.; Brown, R.D.; Calamia, K.T.; Christianson, T.J.; Huston, J. 3rd; Meschia, J.F.; Giannini, C.; Miller, D.V.; Hunder, G.G. Primary CNS vasculitis with prominent leptomeningeal enhancement. A subset with a benign outcome. Arthritis. Rheum., 2008, 58, 595-603.
27. Salvarani, C.; Brown, R.D.; Calamia, K.T.; Christianson, T.J.; Huston, J. 3rd; Meschia, J.F.; Giannini, C.; Miller, D.V.; Hunder, G.G. Angiography negative primary central nervous system vasculitis. A syndrome involving small cerebral vessels. Medicine, 2008, 87, 264-271.
28. Hajj-Ali, R.A.; Calabrese, L. Central nervous system vasculitis. Curr. Opin. Rheumatol., 2009, 21, 10-18.
29. Molloy, E. S.; Langford, C.A. Vasculitis mimics. Curr. Opin. Rheumatol., 2008, 20, 29-34.
30. Harris, K.G.; Tran, D.D.; Sickels, W.J.; Cornell, S.H.; Yuh, W.T. Diagnosing intracranial vasculitis, the roles of MR and angiography. AJNR Am. J. Neuroradiol., 1994, 15, 317-330.
31. Greenan, T.J.; Grossman, R.I.; Goldberg, H.I. Cerebral vasculitis, MR imaging and angiographic correlation. Radiology, 1992, 182, 65-72.
32. Hellmann, D.B.; Roubenoff, R.; Healy, R.A.; Wang, H. Central nervous system angiography, Safety and predictors of a positive result in 125 consecutive patients evaluated for possible vasculitis. J. Rheumatol., 1992, 19, 568-572.
33. Cloft, H.J.; Phillips, C.D.; Dix, J.E.; McNulty, B.C.; Zagardo, M.T.; Kallmes, D.F. Correlation of angiography and MR imaging in cerebral vasculitis. Acta. Radiol., 1999, 40, 83-87.
34. Stone, J.H.; Pomper, M.G.; Roubenoff, R.; Mille, T.J.; Hellmann, D.B. Sensitivities of noninvasive tests for central nervous system vasculitis, a comparison of lumbar puncture; computed tomography; and magnetic resonance imaging. J. Rheumatol., 1994, 21, 1277-1282.
35. White, M.L.; Hadley, W.L.; Zhang, Y.; Dogar, M.A. Analysis of central nervous system vasculitis with diffusion-weighted imaging and apparent diffusion coefficient mapping of the normalappearing brain. Am. J. Neuroradiol., 2007, 28, 933-937.
36. Kraemer, M.; Berlit, P. Primary central nervous system vasculitis: clinical experiences with 21 new European cases. Rheumatol. Int., 2010, 257(7), 816-9.
37. Kraemer, M.; Berlit, P. Systemic, secondary and infectious causes for cerebral vasculitis: clinical experience with 16 new European cases. Rheumatol. Int., 2010, 30, 1471-1476.
38. Vassallo, R.; Remstein, E.; Parisi, J.E.; Huston, J. 3rd; Brown, R.D. Jr. Multiple cerebral infarctions from nonbacterial thrombotic endocarditis mimicking cerebral vasculitis. Mayo Clin. Proc., 1999, 74, 798-802.
39. Salvarani, C.; Brown, R.D. Jr; Calamia, K.T.; Christianson TJ; Huston, J. 3rd; Meschia, J.F.; Giannini, C.; Miller, D.V.; Hunder, G.G. Primary central nervous system vasculitis: comparison of patients with and without cerebral amyloid angiopathy. Rheumatology, 2008, 47, 1671-1677.
40. Mukhtyar, C.; Guillevin, L.; Cid, M.C.; Dasgupta, B.; de Groot, K.; Gross, W.; Hauser, T.; Hellmich, B.; Jayne, D.; Kallenberg, C.G.; Merkel, P.A.; Raspe, H.; Salvarani, C.; Scott, D.G.; Stegeman, C.; Watts, R.; Westman, K.; Witter, J.; Yazici, H.; Luqmani, R.; European Vasculitis Study Group. EULAR recommendations for the management of primary medium vessel vasculitis. Ann. Rheum. Dis., 2009; 68, 310-317.
41. de Groot, K.; Harper, L.; Jayne, D.R.; Flores Suarez, L.F.; Gregorini, G.; Gross, W.L.; Luqmani, R.; Pusey, C.D.; Rasmussen, N.; Sinico, R.A.; Tesar, V.; Vanhille, P.; Westman, K.; Savage, C.O.; EUVAS (European Vasculitis Study Group). Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial. Ann. Intern. Med., 2009, 150, 670-80.
42. Jayne, D.; Rasmussen, N.; Andrassy, K.; Bacon, P.; Tervaert, J.W.; Dadoniené, J.; Ekstrand, A.; Gaskin, G.; Gregorini, G.; de Groot, K.; Gross, W.; Hagen, E.C.; Mirapeix, E.; Pettersson, E.; Siegert, C.; Sinico, A.; Tesar, V.; Westman, K.; Pusey, C.; European Vasculitis Study Group. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N. Engl. J. Med., 2003, 349, 36-44.
43. Pagnoux, C.; Mahr, A.; Hamidou, M.A.; Boffa, J.J.; Ruivard, M.; Ducroix, J.P.; Kyndt, X.; Lifermann, F.; Papo, T.; Lambert, M.; Le Noach, J.; Khellaf, M.; Merrien, D.; Puéchal, X.; Vinzio, S.; Cohen, P.; Mouthon, L.; Cordier, J.F.; Guillevin, L.; French Vasculitis Study Group. Azathioprine or methotrexate maintenance for ANCA-associated vasculitis. N. Engl. J. Med., 2008, 359, 2790-2803.
44. Jones, R.B.; Cohen-Tervaert, J.W.; Hauser, T.; Luqmani, R.; Morgan, M.D.; Peh, C.A.; Savage, C.O.; Segelmark, M.; Tesar, V.; van Paassen, P.; Walsh, D.; Walsh, M.; Westman, K.; Jayne, D.R.; European Vasculitis Study Group. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N. Engl. J. Med., 2010; 363, 211-220.
45. Stone, J.H.; Merkel, P.A.; Spiera, R.; Seo, P.; Langford, C.A.; Hoffman, G.S.; Kallenberg, C.G.; St Clair, E.W.; Turkiewicz, A.; Tchao, N.K.; Webber, L.; Ding, L.; Sejismundo, L.P.; Mieras, K.; Weitzenkamp, D.; Ikle, D.; Seyfert-Margolis, V.; Mueller, M.; Brunetta, P.; Allen, N.B.; Fervenza, F.C.; Geetha, D.; Keogh, K.A.; Kissin, E.Y.; Monach, P.A.; Peikert, T.; Stegeman, C.; Ytterberg, S.R.; Specks, U. RAVE-ITN Research Group. Rituximab versus cyclophophamide for ANCA-associated vasculitis. N. Eng. J. Med., 2010, 363, 221-232.
46. Tokunaga, M.; Saito, K.; Kawabata, D.; Imura, Y.; Fujii, T.; Nakayamada, S.; Tsujimura, S.; Nawata, M.; Iwata, S.; Azuma, T.; Mimori, T.; Tanaka, Y. Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system. Ann. Rheum. Dis., 2007, 66, 470-475.
47. Salvarani, C.; Brown, R.D. Jr; Calamia, K.T.; Huston, J. 3rd; Meschia, J.F.; Giannini, C.; Miller, D.V.; Hunder, G.G. Efficacy of tumor necrosis factor alpha blockade in primary central nervous system vasculitis resistant to immunosuppressive treatment. Arthritis Rheum., 2008, 59, 291-296.
48. Calabrese, L.H.; Dodick, D.W.; Schwedt, T.J.; Singhal, A.B. Reversible Cerebral Vasoconstrictions Syndromes. Ann. Intern. Med., 2007, 146, 34-44.
49. Ducros, A.; Boukobza, M.; Porcher, R.; Sarov, M.; Valade, D.; Bousser, M.G. The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients. Brain, 2007, 130, 3091-3101.
50. Hajj-Ali, R.A.; Furlan, A.; Abou-Chebel, A.; Calabrese, L.H. Benign angiopathy of the central nervous system, cohort of 16 patients with clinical course and long-term followup. Arthritis. Rheum., 2002, 47, 662-669.
51. Lu, S.R.; Liao, Y.C.; Fuh, J.L.; Liang, J.F.; Wang SJ. Nimodipine for treatment of primary thunderclap headache. Neurology, 2004, 62, 1414-1416.
52. Calabrese, L.H.; Molloy, E.S.; Singhal, A.B. Primary central nervous system vasculitis: progress and questions. Ann. Neurol., 2007, 62, 430-432.
53. Zivkovic, S.; Moore, P.M. Systemic and central nervous system vasculitis. Curr. Treat. Options Neurol., 2000, 2, 459-472.
54. Guillevin, L.; Lhote, F.; Gayraud, M.; Cohen, P.; Jarrousse, B.; Lortholary, O.; Thibult, N.; Casassus, P. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients. Medicine (Baltimore), 1996, 75, 17-28.
55. Bourgarit, A.; Le Toumelin, P.; Pagnoux, C.; Cohen, P.; Mahr, A.; Le Guern, V.; Mouthon, L.; Guillevin, L.; French Vasculitis Study Group. Deaths occurring during the first year after treatment onset for polyarteritis nodosa; microscopic polyangiitis; and Churg- Strauss syndrome, a retrospective analysis of causes and factors predictive of mortality based on 595 patients. Medicine (Baltimore), 2005, 84, 323-330.
56. Mukhtyar, C.; Guillevin, L.; Cid, M.C.; Dasgupta, B.; de Groot, K.; Gross, W.; Hauser, T.; Hellmich, B.; Jayne, D.; Kallenberg, C.G.; Merkel, P.A.; Raspe, H.; Salvarani, C.; Scott, D.G.; Stegeman, C.; Watts, R.; Westman, K.; Witter, J.; Yazici, H.; Luqmani, R. European Vasculitis Study Group. EULAR recommendations for the management of large- vessel vasculitis. Ann. Rheum. Dis., 2009, 68, 318-323.
57. Espígol-Frigolé, G.; Gómez-Choco, M.; Obach, V.; Sanroman, L.; Prieto, S.; Argelich, R.; Grau, J.M.; Cid, M.C. Percutaneous transluminal angioplasty of internal carotid and vertebral arteries in giant-cell arteritis: report of 2 cases. APMIS, 2009, 117 (suppl), 104-105.
58. Maksimowicz-McKinnon, K.; Clark, T.M.; Hoffman, G.S. Limitations of therapy and a guarded prognosis in an American cohort of Takayasu arteritis patients. Arthritis Rheum., 2007, 56, 1000-1009.
59. Hoffman, G.S.; Kerr, G.S.; Leavitt, R.Y.; Hallahan, C.W.; Lebovics, R.S.; Travis, W.D.; Rottem, M.; Fauci, A.S. Wegener granulomatosis: an analysis of 158 patients. Ann. Intern. Med., 1992, 116, 488-498.
60. Reinhold-Keller, E.; Beuge, N.; Latza, U.; de Groot, K.; Rudert, H.; Nölle, B.; Heller, M.; Gross, W.L. An interdisciplinary approach to the care of patients with Wegener's granulomatosis, long-term outcome in 155 patients. Arthritis Rheum., 2000, 43, 1021-1032.
61. Stone, J.H. Wegener's Granulomatosis Etanercept Trial Research Group. Limited versus severe Wegener's granulomatosis, baseline data on patients in the Wegener's granulomatosis etanercept trial. Arthritis Rheum., 2003, 48, 2299-2309.
62. Nishino, H.; Rubino, F.A.; DeRemee, R.A.; Swanson, J.W.; Parisi, J.E. Neurological involvement in Wegener's granulomatosis: an analysis of 324 consecutive patients at the Mayo Clinic. Ann. Neurol., 1993, 33, 4-9.
63. Seror, R.; Mahr, A.; Ramanoelina, J.; Pagnoux, C.; Cohen, P.; Guillevin, L. Central nervous system involvement in Wegener granulomatosis. Medicine (Baltimore), 2006, 85, 54-65.
64. Di Comite, G.; Bozzolo, E.P.; Praderio, L.; Tresoldi, M.; Sabbadini, M.G. Meningeal involvement in Wegener's granulomatosis is associated with localized disease. Clin. Exp. Rheumatol., 2006, 24, S60-64.
65. Di Comite, G.; Bozzolo, E.; Bianchi, S.; Sabbadini, M.G. Two cases of meningeal involvement in Wegener's granulomatosis. Rheumatology (Oxford), 2004, 43, 1459-1460.
66. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 9-1999. A 74-year-old woman with hydrocephalus and pleocytosis. N. Engl. J. Med., 1999, 340, 945-953.
67. Guillevin, L.; Durand-Gasselin, B.; Cevallos, R.; Gayraud, M.; Lhote, F.; Callard, P.; Amouroux, J.; Casassus, P.; Jarrousse, B. Microscopic polyangiitis, clinical and laboratory findings in eightyfive patients. Arthritis Rheum., 1999, 42, 421-430.
68. Ku, B.D.; Shin, H.Y. Multiple bilateral non-hemorrhagic cerebral infarctions associated with microscopic polyangiitis. Clin. Neurol. Neurosurg., 2009, 111, 904-906.
69. Sasaki, A.; Hirato, J.; Nakazato, Y.; Tanaka, T.; Takeuchi, H. An autopsy case of P-ANCA-positive microscopic polyangiitis with multiple cerebral hemorrhagic infarction. No To Shinkei, 1998, 50, 56-60.
70. Tang, C.W.; Wang, P.N.; Lin, K.P.; Huang, D.F.; Wang, S.J.; Chen, W.T. Microscopic polyangiitis presenting with capsular warning syndrome and subsequent stroke. J. Neurol. Sci., 2009, 277, 174-175.
71. Furukawa, Y.; Matsumoto, Y.; Yamada, M. Hypertrophic pachymeningitis as an initial and cardinal manifestation of microscopic polyangiitis. Neurology, 2004, 63, 1722-1724.
72. Kono, H.; Inokuma, S.; Nakayama, H.; Yamazaki, J. Pachymeningitis in microscopic polyangiitis (MPA), a case report and a review of central nervous system involvement in MPA. Clin. Exp. Rheumatol., 2000, 18, 397-400.
73. Keogh, K.A.; Specks, U. Churg-Strauss syndrome, clinical presentation; antineutrophil cytoplasmic antibodies; and leukotriene receptor antagonists. Am. J. Med., 2003, 115, 284-290.
74. Sinico, R.A.; Di Toma, L.; Maggiore, U.; Bottero, P.; Radice, A.; Tosoni, C.; Grasselli, C.; Pavone, L.; Gregorini, G.; Monti, S.; Frassi, M.; Vecchio, F.; Corace, C.; Venegoni, E.; Buzio, C. Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome. Arthritis Rheum., 2005, 52, 2926-2935.
75. Guillevin, L.; Cohen, P.; Gayraud, M.; Lhote, F.; Jarrousse, B.; Cassasus, P. Churg-Strauss syndrome, clinical study and long-term follow-up of 96 patients. Medicine, 1999, 78, 26-37.
76. Sablé-Fourtassou, R.; Cohen, P.; Mahr, A.; Pagnoux, C.; Mouthon, L.; Jayne, D.; Blockmans, D.; Cordier, J.F.; Delaval, P.; Puechal, X.; Lauque, D.; Viallard, J.F.; Zoulim, A.; Guillevin, L.; French Vasculitis Study Group. Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome. Ann. Intern. Med., 2005, 143, 632-638.
77. Solans, R.; Bosch, J.A.; Pérez-Bocanegra, C.; Selva, A., Huguet, P., Alijotas, J.; Orriols, R.; Armadans, L.; Vilardell, M. Churg- Strauss syndrome, outcome and long-term follow-up of 32 patients. Rheumatology, 2001, 40, 763-771.
78. Liou, H.H.; Liu, H.M.; Chiang, I.P.; Yeh, T.S.; Chen RC. Churg- Strauss syndrome presented as multiple intracerebral hemorrhage. Lupus, 1997, 6, 279-282.
79. Sheerin, U.M.; Barreto, J.; Brown, M.M.; Brew, S.; Losseff, N.A. Subarachnoid haemorrhage as the first clinicalmanifestation of Churg-Strauss syndrome. J. Neurol., 2008, 255, 607-608.
80. Tokumaru, A.M.; Obata, T.; Kohyama, S.; Kaji, T.; Okizuka, H; Suzuki, K.; Kusano, S. Intracranial meningeal involvement in Churg-Strauss syndrome. Am. J. Neuroradiol., 2002, 23, 221-224.
81. Lio, M.; Fukuda, S.; Maguchi, S.; Kawanami, M.; Inuyama, Y. Churg-Strauss syndrome with pachymeningitis refractory to steroid therapy alone-a case report. Auris Nasus Larynx, 2001, 28, S121-125.
82. Pagnoux, C.; Seror, R.; Henegar, C.; Mahr, A.; Cohen, P.; Le Guern, V.; Bienvenu, B.; Mouthon, L.; Guillevin, L.; French Vasculitis Study Group. Clinical features and outcomes in 348 patients with polyarteritis nodosa, a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database. Arthritis Rheum., 2010, 62, 616-626.
83. Rosenberg, M.R.; Parshley, M.; Gibson, S.; Wernick, R. Central nervous system polyarteritis nodosa. West. J. Med., 1990, 153, 553-556.
84. Basu, N.; Watts, R.; Bajema, I.; Baslund, B.; Bley, T.; Boers, M.; Brogan, P.; Calabrese, L.; Cid, M.C.; Cohen-Tervaert, J.W.; Flores-Suarez, L.F.; Fujimoto, S.; de Groot, K.; Guillevin, L.; Hatemi, G.; Hauser, T.; Jayne, D.; Jennette, C.; Kallenberg, C.G.; Kobayashi, S.; Little, M.A.; Mahr, A.; McLaren, J.; Merkel, P.A.; Ozen, S.; Puechal, X.; Rasmussen, N.; Salama, A.; Salvarani, C.; Savage, C.; Scott, D.G.; Segelmark, M.; Specks, U.; Sunderköetter, C.; Suzuki, K.; Tesar, V.; Wiik, A.; Yazici, H.; Luqmani, R. EULAR points toconsider in the development of classification and diagnostic criteria in systemic vasculitis. Ann. Rheum. Dis., 2010, 69, 1744-1750.
85. Provenzale, J.M.; Allen, N.B. Neuroradiologic findings in polyarteritis nodosa. Am. J. Neuroradiol., 1996, 17, 1119-1126.
86. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 3-2003. A 36-year-old man with renal failure; hypertension and neurologic abnormalities. N. Engl. J. Med., 2003, 348, 333-342.
87. Ramos-Casals, M.; Robles, A.; Brito-Zerón, P.; Nardi, N.; Nicolas, J.M.; Forns, X.; Plaza, J.; Yagüe, J.; Sánchez-Tapias, J.M.; Font, J. Life- threatening cryoglobulinemia: clinical and immunologic characterization of 29 cases. Semin. Artritis Rheum., 2006, 36, 189-196.
88. Casato, M.; Saadoun, D.; Marchetti, A.; Limal, N.; Picq, C.; Pantano, P.; Galanaud, D.; Cianci, R.; Duhaut, P.; Piette, J.C.; Fiorilli, M.; Cacoub, P. Central nervous system involvement in hepatitis C virus cryoglobulinemia vasculitis, a multicenter casecontrol study using magnetic resonance imaging and neuropsychological tests. J. Rheumatol., 2005, 32, 484-488.
89. Origgi, L.; Vanoli, M.; Carbone, A.; Grasso, M.; Scorza, R. Central nervous system involvement in patients with HCV-related cryoglobulinemia. Am. J. Med. Sci., 1998, 315, 208-210.
90. Petty, G.W.; Duffy, J.; Huston, J. Cerebral ischemia in patients with hepatitis C virus infection and mixed cryoglobulinemia. Mayo Clin. Proc., 1996, 71, 671-678.
91. Al-Araji, A.; Sharquie, K.; Al-Rawi, Z. Prevalence and patterns of neurological involvement in Behçet's disease, a prospective study from Iraq. J. Neurol. Neurosurg. Psychiatry, 2003, 74, 608-613.
92. Ashjazadeh, N.; Borhani Haghighi, A.; Samangooie, S.; Moosavi, H. Neuro-Behçet's disease, a masquerader of multiple sclerosis. A prospective study of neurologic manifestations of Behçet's disease in 96 Iranian patients. Exp. Mol. Pathol., 2003, 74, 17-22.
93. Al-Araji, A.; Kidd, D.P. Neuro-Behçet's disease, epidemiology; clinical characteristics; and management. Lancet Neurol., 2009, 8 (2), 192-204.
94. Akman-Demir, G.; Serdaroglu, P.; Tasçi, B. Clinical patterns of neurological involvement in Behçet's disease, evaluation of 200 patients. The Neuro-Behçet Study Group. Brain, 1999, 122, 2171-2182.
95. Lee, S.H.; Yoon, P.H.; Park, S.J.; Kim, D.I. MRI findings in neuro- Behçet's disease. Clin. Radiol., 2001, 56, 485-494.
96. Esteban, M.J.; Font, C.; Hernández-Rodríguez, J.; Valls-Solé, J.; Sanmartí, R.; Cardellach, F.; García-Martínez, A.; Campo, E.; Urbano-Márquez, A.; Grau, J.M.; Cid, M.C. Small-vessel vasculitis surrounding a spared temporal artery: clinical and pathological findings in a series of twenty-eight patients. Arthritis Rheum., 2001, 44, 1387-1395.
97. Cid, M.C.; Font, C.; Oristrell, J.; de la Sierra, A.; Coll-Vinent, B.; López-Soto, A.; Vilaseca, J.; Urbano-Márquez, A.; Grau, J.M. Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis. Arthritis Rheum., 1998, 41, 26-32.
98. González-Gay, M.A.; García-Porrua, C.; Llorca, J.; Hajeer, A.H.; Brañas, F.; Dababneh, A; González-Louzao, C.; Rodriguez-Gil, E.; Rodríguez-Ledo, P.; Ollier, W.E. Visual manifestations of giant cell arteritis: trends and clinical spectrum in 161 patients. Medicine (Baltimore), 2000, 79, 283-292.
99. Cid, M.C.; García-Martínez, A.; Lozano, E.; Espígol-Frigolé, G.; Hernández-Rodríguez, J. Five clinical conundrums in the management of giant-cell arteritis. Rheum. Dis. Clin. North Am., 2007, 33, 819-834.
100. Cid, M.C.; Prieto-González, S.; Arguis, P.; Espígol-Frigolé, G.; Butjosa, M.; Hernández-Rodríguez, J.; Segarra, M.; Lozano, E.; García-Martínez, A. The spectrum of vascular involvement in giant-cell arteritis: clinical consequences of detrimental vascular remodelling at different sites. APMIS, 2009, 117 (suppl), 10-20.
101. Hayreh, S.S.; Zimmerman, B. Visual deterioration in giant cell arteritis patients while on high doses of glucocorticoid therapy. Ophthalmology, 2003, 110, 1204-1215.
102. Hayreh, S.S.; Zimmerman, B.; Kardon, R.H. Visual improvement with corticosteroid therapy in giant cell arteritis. Report of a large study and review of literature. Acta Ophthalmol. Scand., 2002, 80, 353-367.
103. Gonzalez-Gay, M.A.; Vazquez-Rodriguez, T.R.; Gomez-Acebo, I.; Pego-Reigosa, R.; Lopez-Diaz, M.J.; Vázquez-Triñanes, M.C.; Miranda-Filloy, J.A.; Blanco, R.; Dierssen, T.; Gonzalez-Juanatey, C.; Llorca, J. Strokes at time of disease diagnosis in a series of 287 patients with biopsy-proven giant cell arteritis. Medicine (Baltimore), 2009, 88, 227-235.
104. Solans-Laqué, R.; Bosch-Gil, J.A.; Molina-Catenario, C.A.; Ortega-Aznar, A.; Alvarez-Sabin, J.; Vilardell-Tarres, M. Stroke and multi-infarct dementia as presenting symptoms of giant cell arteritis, report of 7 cases and review of the literature. Medicine (Baltimore), 2008, 87, 335-344.
105. Brack, A.; Martinez-Taboada, V.; Stanson, A.; Goronzy, J.J.; Weyand, C.M. Disease pattern in cranial and large-vessel giant cell arteritis. Arthritis Rheum., 1999, 42, 311-317.
106. Nuenninghoff, D.M.; Hunder, G.G.; Christianson, T.J.; McClelland, R.L.; Matteson, E.L. Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and/or largeartery stenosis) in patients with giant cell arteritis: a populationbased study over 50 years. Arthritis Rheum., 2003, 48, 3522-3531.
107. Schmidt, W.A.; Seifert, A.; Gromnica-Ihle, E.; Krause, A.; Natusch, A. Ultrasound of proximal upper extremity arteries to increase the diagnostic yield in large-vessel giant cell arteritis. Rheumatology, 2008, 47, 96-101.
108. Salvarani, C.; Cimino, L.; Macchioni, P.; Consonni, D.; Cantini, F.; Bajocchi, G.; Pipitone, N.; Catanoso, M.G.; Boiardi, L. Risk factors for visual loss in an Italian population-based cohort of patients with giant cell arteritis. Arthritis Rheum., 2005, 53, 293-297.
109. Aiello, P.D.; Trautmann, J.C.; McPhee, T.J.; Kunselman, A.R.; Hunder, G.G. Visual prognosis in giant-cell arteritis. Ophthalmology, 1993, 100, 550-555.
110. Kerr, G.S.; Hallahan, C.W.; Giordano, J.; Leavitt, R.Y.; Fauci, A.S.; Rottem, M. Hoffman, G.S. Takayasu arteritis. Ann. Intern. Med., 1994, 120, 919-929.
111. Vanoli, M.; Daina, E.; Salvarani, C.; Sabbadini, M.G.; Rossi, C.; Bacchiani, G.; Schieppati, A.; Baldissera, E.; Bertolini, G. Itaka Study Group. Takayasu's arteritis, A study of 104 Italian patients. Arthritis Rheum., 2005, 53, 100-107.
112. Kim, H.J.; Suh, D.C.; Kim, J.K.; Kim, S.J.; Lee, J.H.; Choi, C.G.; Yoo, B.; Kwon, S.U.; Kim, J.S. Correlation of neurological manifestations of Takayasu's arteritis with cerebral angiographic findings. Clin. Imaging, 2005, 29, 79-85.
113. Ringleb, P.A.; Strittmatter, E.I.; Loewer, M.; Hartmann, M.; Fiebach, J.B.; Lichy, C.; Weber, R.; Jacobi, C.; Amendt, K.; Schwaninger, M. Cerebrovascular manifestations of Takayasu arteritis in Europe. Rheumatology, 2005, 44, 1012-1015.
114. Molnár, P.; Hegedüs, K. Direct involvement of intracerebral arteries in Takayasu's arteritis. Acta. Neuropathol., 1984, 63, 83-86.
115. Alba, M.A.; Espígol-Frigolé, G.; Butjosa, M.; Prieto-González, S; García-Martínez, A.; Hernández-Rodríguez J.; Cid, M.C. Treatment of large-vessel vasculitis. Curr. Immunol. Rev., 2011, (in press).
116. Molloy, E.S.; Langford, C.A.; Clark, T.M.; Gota, C.E.; Hoffman, G.S. Anti-tumour necrosis factor therapy in patients with refractory Takayasu arteritis: long-term follow-up. Ann. Rheum. Dis., 2008, 67, 1567-1569.